Health Populi

JULY 1, 2020

To the pharmaceutical industry, it’s the annual revenue generated from 323 blockbuster drugs, as “blockbusters” are defined as products yielding $1 bn in sales a year. Hospitals Will Lose $323 Billion in 2020 – Before Accounting for Growing COVID Cases appeared first on HealthPopuli.com. The post U.S.

Accountability 127

Accountability Hospitals Doctors Pharmaceuticals 127

Bill Of Health

MARCH 13, 2025

Salix Pharmaceuticals v. Norwich and Vanda Pharmaceuticals Inc. Greater transparency is indeed possibleand beneficialso long as policymakers account for the unintended IP-related consequences of routine clinical trial data postings. Similarly, in Vanda Pharmaceuticals v. In the U.S., For the U.S. For the U.S.

Pharmaceuticals 52

Pharmaceuticals Life Sciences Regulations Accountability 52

HIT Consultant

NOVEMBER 20, 2024

– Peter Doumas, Chief Revenue Officer: Former Vice President of National Key Accounts at Progyny and Anthem. Kumar Dharmarajan, Chief Medical Officer: Former Chief Scientific Officer at Clover Health and a professor at Yale University.

Doctors 97

Doctors Pharmaceuticals Nursing Medicare 97

Healthcare ECONOMIST

JULY 11, 2024

CONCLUSIONS : Although sotagliflozin adoption reduced health system revenue in an FFS payment model, it led to a net positive financial impact after accounting for APM bonus payments. RESULTS : A typical community hospital would have 83.4 patients per year on average with an index HF hospitalization with comorbid DM.

Pharmaceuticals 84

Pharmaceuticals Accountable Care Accountability Hospitals 84

Bill Of Health

JULY 20, 2022

Section 340B of the Public Health Service Act requires that pharmaceutical manufacturers give discounts on specified outpatient drugs to certain covered entities who typically serve low-income or otherwise underserved patients, including hospitals and clinics. billion and accounting for a third of U.S. billion, reaching $6.3

Pharmaceuticals 59

Pharmaceuticals Hospitals Public Health services Accountability 59

Beterra

FEBRUARY 20, 2025

As a licensed pharmacist, she has played a critical role in ensuring the safe and effective delivery of pharmaceutical care to her community. This relentless drive to elevate rural healthcare fuels Jessicas work, propelling forward a culture of excellence, accountability, and innovation.

Patient Safety 98

Patient Safety Pharmaceuticals Quality Improvement Healthcare Innovation 98

HIT Consultant

NOVEMBER 25, 2024

Starting with clinical trial site selection, the age-old process of designing and planning a clinical trial—which, in most cases, has not evolved for the last two decades —involves a pharmaceutical sponsor working with a contract research organization (CRO) to identify several clinical sites from their clinician networks.

Life Sciences 98

Life Sciences Pharmaceuticals Integration Regulations 98

HIT Consultant

JANUARY 27, 2025

Personalized Treatment Plans Traditional treatments often rely on standardized protocols that fail to account for the unique characteristics of individual patients. AI is revolutionizing pharmaceuticals and clinical research by significantly accelerating drug discovery and development.

Healthcare 99

Healthcare Life Sciences Pharmaceuticals Public Hospital 99

HIT Consultant

AUGUST 15, 2011

The second part interview where Host, Gina Clark, Chief Marketing Officer for AmerisourceBergen interviews Loreen Brown, VP of Access and Reimbursement for Xcenda to share her insights on the impact of Accountable Care Organizations on healthcare delivery. For more information, visit amerisourcebergen.com.

Accountable Care 52

Accountable Care Accountability Pharmaceuticals Healthcare 52

NCQA

DECEMBER 18, 2024

Lack of standardized performance measures makes it difficult to hold health systems and clinicians accountable for equitable care. Goal 4: Ensure adequate resources to enforce existing laws and build systems of accountability that explicitly focus on eliminating health care inequities and advancing health equity.

Quality Assurance 52

Quality Assurance Accountability Quality Improvement Pharmaceuticals 52

Healthcare ECONOMIST

JULY 3, 2024

Created in 1992, the program requires pharmaceutical manufacturers to sell outpatient drugs at significantly discounted prices (typically 25% to 50% off) to eligible hospitals, clinics, and health centers that care for a large number of uninsured and low-income patients. Why would 340B increase cost?

Medicaid 119

Medicaid Pharmaceuticals Hospitals Accountability 119

Bill Of Health

OCTOBER 29, 2021

The Doha Declaration , enacted in 2001, attempts to address global inequities stemming from intellectual property protections by allowing countries to grant compulsory licenses for the production of pharmaceuticals for international exports. Accountability mechanisms are also imperative to ensure the facility’s effective functioning.

Pharmaceuticals 144

Pharmaceuticals Accountability Prevention Biotechnology 144

Healthcare ECONOMIST

SEPTEMBER 20, 2021

To account for rebates in the US they use SSR Health information Then international prices are identified based on the IQVIA MIDAS data across 6 markets (Australia, Canada, France, Germany, Japan, and the U.K). The authors use IQVIA MIDAS data to estimate sales price and volume in the US. Title II of H.R.

Pharmaceuticals 114

Pharmaceuticals Life Sciences Accountability 114

Bill Of Health

OCTOBER 28, 2022

The selections feature topics ranging from an examination of Park doctrine prosecutions of executives of pharmaceutical and medical device companies, an analysis of patent thickets covering biologic drugs, and a discussion of product hopping strategies among manufacturers of inhalers. The Political Economy of Market Power in Pharmaceuticals.

Pharmaceuticals 96

Pharmaceuticals Regulations Accountability Medicaid 96

Bill Of Health

DECEMBER 27, 2021

Engaging parameters,” accountability and benefit , redirect attention from those who experience injustice to those who contribute to or enjoy from the status quo. While the engagement of the UN , WHO , or governments is obvious, the accountability parameter may also engage other stakeholders to sit at the table.

Accountability 105

Accountability Pharmaceuticals Regulations Prevention 105

Healthcare ECONOMIST

DECEMBER 17, 2023

The share of the economy accounted for by the health sector was 17.3 Pharmaceutical spending as a share of total health care spending has been relatively constant at around 9% throughout the past 7 years. The insured share of the population reached a historic high of 92.0 percent in 2022, which was down from a peak of 19.5

Pharmaceuticals 115

Pharmaceuticals Medicaid Accountability 115

HIT Consultant

JULY 25, 2022

Lauren Ohlsson, Lead of Industry Solutions, Pharmaceutical and Healthcare, at VDX.tv. Consumers continue to cut ties with traditional TV and cable services, prompting industries like the prescription pharmaceutical industry to evolve their marketing mix to accommodate emerging media. . About Lauren Ohlsson.

Pharmaceuticals 98

Pharmaceuticals Accountability Regulations Integration 98

HIT Consultant

DECEMBER 7, 2023

Lance Hill, CEO of Within3 The cancer market for the pharma industry accounts for about a third of their product pipeline. In this nuanced landscape, pharmaceutical companies play a vital role in driving advancements in cancer care. A recent study estimated the cost of developing a new drug at $2.6

Life Sciences 98

Life Sciences Pharmaceuticals Accountability Healthcare Improvement 98

Healthcare ECONOMIST

JUNE 13, 2022

Despite these positive impacts, a number of political commentators have accused pharmaceutical companies of profiteering. Clinical trial costs account for 94% of the total investment, with manufacturing costs accounting for only 6%. A study by Ahuja et al. trillion in social value. per annum and a net present value of –$9.5

Life Sciences 105

Life Sciences Pharmaceuticals Accountability Prevention 105

Bill Of Health

OCTOBER 26, 2023

However, the deep wounds of the pandemic remain, compelling those concerned about this pandemic and future health emergencies to account for catastrophic failures by those in power. That has created deep inequities in access to health products that can save lives.

Accountability 121

Accountability Prevention Pharmaceuticals Regulations 121

HIT Consultant

SEPTEMBER 26, 2022

The new normal has thrown up opportunities as well as risks for pharmaceutical companies. Nevertheless, there is a downward trend in the consumption of prescription medicine due to lower spending, apart from increased competition from generics and rising instances of pharmaceutical fraud and counterfeiting that lead to consumer distrust (2).

Life Sciences 97

Life Sciences Pharmaceuticals Telemedicine Healthcare Providers 97

Healthcare ECONOMIST

MARCH 22, 2022

Based on analysis from National Income and Product Accounts (NIPAs), multifactor productivity (MFP) in the health care and social assistance sector declined by 0.4% Another issue is that in national accounts, each provider type (e.g., hospitals, physicians, pharmaceuticals) is treated as a separate industry. increase in MFP.

Pharmaceuticals 75

Pharmaceuticals Accountability Medicare Hospitals 75

Healthcare ECONOMIST

AUGUST 1, 2022

For large publicly traded pharmaceutical firms, research and other costs are public on their financial statements. It may appear on financial statements that successful pharmaceutical make outsized profits, but these figures must also take into account that many pharmaceutical firms have drugs that fail and the companies go out of business.

Pharmaceuticals 75

Pharmaceuticals Biotechnology Accountability 75

HIT Consultant

APRIL 15, 2024

In fact, in 2018, 80% of all biopharma pipeline projects in JAPAC were EBPs, accounting for 75% of the total clinical trial volume in the region. They are also in communication with the sponsor, who is the MAH of the active pharmaceutical ingredient. In comparison to Japan, China has fewer distinctions.

Pharmaceuticals 96

Pharmaceuticals Patient Safety Accountability Integration 96

Healthcare ECONOMIST

MAY 31, 2022

Even if IRP was implemented however, IRP programs differ across a number dimensions including: Number/type of countries referenced Method of calculating prices (eg, minimum, median, mean, or a weighted index of referenced countries); How the prices are obtained (eg, from pharmaceutical manufacturer or external sources); Type of price used (e.g.,

Pharmaceuticals 81

Pharmaceuticals Accountability 81

Healthcare ECONOMIST

OCTOBER 19, 2023

However, CEAs in the past have rarely accounted for these possibilities and instead assume that a drug’s price remains constant over time. A static drug pricing assumption fails to account for anticipated savings from the genericization of the alternative treatment.

Pharmaceuticals 88

Pharmaceuticals Accountability 88

Healthcare ECONOMIST

JANUARY 31, 2025

uAMCE does not take into account that a PFS(high)OS(high) or PFS(low)OS(low) profile is much much more likely than a PFS(high)OS(low) or PFS(low)OS(high) attribute profile. One reason RWD may be limited is that researchers may want to look at patient preferences for new pharmaceutical treatments relative to those already on the market.

Life Sciences 40

Life Sciences Accountability Pharmaceuticals 40

HIT Consultant

MAY 2, 2022

The pharmaceutical industry differs in many ways from other industries. Along this entire path, the organization must ensure that diverse voices are included and the needs of diverse patient populations are taken into account. Diversity needs to become part of the fabric of pharmaceutical companies and the industry as a whole.

Life Sciences 98

Life Sciences Pharmaceuticals Healthcare Providers Healthcare 98

HIT Consultant

AUGUST 5, 2022

Supply costs are often less significant in the cost structure of PPM companies, and campaigns run by large drug companies in an effort to increase market share for pharmaceuticals coming off patent expiration may generate additional opportunities for PPM companies to achieve higher margins on J-Code drug billing.

Life Sciences 98

Life Sciences Telemedicine Healthcare Biotechnology 98

HIT Consultant

OCTOBER 20, 2023

According to a study in the Journal of the American Geriatric Society , non-fatal falls cost an estimated $50 billion in medical expenses, while fatal falls account for an estimated $754 million. Prior to Dominion, Dr. Fornari was a research scientist and consultant to the pharmaceutical industry. It is also an expensive problem.

Rehabilitation 105

Rehabilitation Pharmaceuticals Prevention Biotechnology 105

Healthcare Success

MAY 24, 2022

Today, virtually every type of healthcare business markets, including health systems, hospitals, multilocation providers, solo practices, pharmaceuticals, medical device manufacturers, health plans, consumer brands, and more. Your medical marketing strategy must account for every consumer touchpoint. Keep it simple.

Healthcare 256

Healthcare Doctors Patient Experience Hospitals 256

Healthcare Success

JULY 5, 2022

Generally speaking, doctors control large sums of money both professionally and personally, making them a highly desirable target audience for pharmaceutical companies, device and supply companies, SaaS, and even those outside the healthcare industry, like real estate brokers and investment advisors.

Doctors 148

Doctors Private Practices Accountability Hospitals 148

Health Populi

AUGUST 7, 2018

One-third of large employers will adopt new delivery and payment models like accountable care organizations and high-performing networks in 2019. One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. orthopedic/musculoskeletal, and fertility.

Pharmaceuticals 78

Pharmaceuticals Telemedicine Accountability Accountable Care 78

Healthcare ECONOMIST

AUGUST 29, 2021

The figure below show this impact graphically, accounting for uncertainty in some of the underlying parameters. The modelling approach basically uses a hurdle model where pharmaceutical firms only enter the next phase of development (i.e., Phase 1, 2 or 3) if the expected benefits exceed the cost. the cost of capital).

Life Sciences 94

Life Sciences Pharmaceuticals Medicare Accountability 94

HIT Consultant

JANUARY 30, 2024

Price of Specialty Medications The majority of the top 15 medications in spend among Vizient pharmacy program participants fall under specialty pharmaceuticals, addressing high-cost, complex, or chronic conditions such as cancer, infectious diseases, autoimmune disorders, and pulmonary conditions.

Pharmaceuticals 98

Pharmaceuticals Performance improvement Accountability Prevention 98

Healthcare ECONOMIST

AUGUST 8, 2022

The national Dental and Pharmaceutical Benefits Agency (TLV), regulates which drugs are included in the national pharmaceutical benefits scheme based on health need, disease severity, and cost-effectiveness…If a drug is approved, it is sold at private pharmacies throughout the country at the fixed price agreed by the producer and TLV.

Pharmaceuticals 75

Pharmaceuticals Regulations Accountability Medicare 75

Healthcare ECONOMIST

DECEMBER 13, 2021

The key findings from the article are: HTA practices are designed to be used for medical technologies and pharmaceuticals that treat commonly-occurring diseases, and are not fit to determine the value of orphan drugs for rare disease, which face unique challenges. That is a title of a new white paper from FTI Consulting and Alexion.

Medical Technology 75

Medical Technology Pharmaceuticals Accountability 75